|Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review|
BM Mathers, L Degenhardt, B Phillips, L Wiessing, M Hickman, ...
The Lancet 372 (9651), 1733-1745, 2008
|The natural history of hepatitis C virus infection: host, viral, and environmental factors|
DL Thomas, J Astemborski, RM Rai, FA Anania, M Schaeffer, N Galai, ...
Jama 284 (4), 450-456, 2000
|The social structural production of HIV risk among injecting drug users|
T Rhodes, M Singer, P Bourgois, SR Friedman, SA Strathdee
Social science & medicine 61 (5), 1026-1044, 2005
|Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States|
SH Mehta, FL Brancati, MS Sulkowski, SA Strathdee, M Szklo, DL Thomas
Annals of internal medicine 133 (8), 592-599, 2000
|Needle exchange is not enough: lessons from the Vancouver injecting drug use study|
SA Strathdee, DM Patrick, SL Currie, PGA Cornelisse, ML Rekart, ...
Aids 11 (8), F59-F65, 1997
|HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage|
BM Mathers, L Degenhardt, H Ali, L Wiessing, M Hickman, RP Mattick, ...
The Lancet 375 (9719), 1014-1028, 2010
|Global epidemiology of HIV among female sex workers: influence of structural determinants|
K Shannon, SA Strathdee, SM Goldenberg, P Duff, P Mwangi, ...
The Lancet 385 (9962), 55-71, 2015
|Barriers to use of free antiretroviral therapy in injection drug users|
SA Strathdee, A Palepu, PGA Cornelisse, B Yip, MV O'Shaughnessy, ...
Jama 280 (6), 547-549, 1998
|Protection against persistence of hepatitis C|
SH Mehta, A Cox, DR Hoover, XH Wang, Q Mao, S Ray, SA Strathdee, ...
The Lancet 359 (9316), 1478-1483, 2002
|HIV and risk environment for injecting drug users: the past, present, and future|
SA Strathdee, TB Hallett, N Bobrova, T Rhodes, R Booth, R Abdool, ...
The Lancet 376 (9737), 268-284, 2010
|The social epidemiology of human immunodeficiency virus/acquired immunodeficiency syndrome|
KE Poundstone, SA Strathdee, DD Celentano
Epidemiologic reviews 26 (1), 22-35, 2004
|Hepatitis C virus infection and incident type 2 diabetes|
SH Mehta, FL Brancati, SA Strathdee, JS Pankow, D Netski, J Coresh, ...
Hepatology 38 (1), 50-56, 2003
|Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care|
LI Gardner, LR Metsch, P Anderson-Mahoney, AM Loughlin, C Del Rio, ...
Aids 19 (4), 423-431, 2005
|Height, leg length, and cancer risk: a systematic review|
D Gunnell, M Okasha, G Davey Smith, SE Oliver, J Sandhu, JMP Holly
Epidemiologic reviews 23 (2), 313-342, 2001
|Sex differences in risk factors for HIV seroconversion among injection drug users: a 10-year perspective|
SA Strathdee, N Galai, M Safaiean, DD Celentano, D Vlahov, L Johnson, ...
Archives of internal medicine 161 (10), 1281-1288, 2001
|Limited uptake of hepatitis C treatment among injection drug users|
SH Mehta, BL Genberg, J Astemborski, R Kavasery, GD Kirk, D Vlahov, ...
Journal of community health 33 (3), 126, 2008
|Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men|
DE Ostrow, KJ Fox, JS Chmiel, A Silvestre, BR Visscher, PA Vanable, ...
Aids 16 (5), 775-780, 2002
|The role of sexual transmission of HIV infection among injection and non-injection drug users|
SA Strathdee, SG Sherman
Journal of Urban Health 80 (3), iii7-iii14, 2003
|Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study|
L Kingsley, LP Jacobson
J Acqui Immune Defic Syndr 26, 8292, 2001
|Prevalence and structural correlates of gender based violence among a prospective cohort of female sex workers|
K Shannon, T Kerr, SA Strathdee, J Shoveller, JS Montaner, MW Tyndall
Bmj 339, b2939, 2009